Decreased Fertility in Women with Cesarean Scar Syndrome Is Associated with Chronic Inflammation in the Uterine Cavity.


Journal

The Tohoku journal of experimental medicine
ISSN: 1349-3329
Titre abrégé: Tohoku J Exp Med
Pays: Japan
ID NLM: 0417355

Informations de publication

Date de publication:
26 Oct 2022
Historique:
pubmed: 17 10 2022
medline: 29 10 2022
entrez: 16 10 2022
Statut: ppublish

Résumé

Chronic inflammation in cesarean scar defect contributes to secondary infertility in women with cesarean scar syndrom; however, it remains unclear about the situation of inflammation in uterine cavity in women with cesarean scar syndrome. This ambidirectional cohort study aimed to explore the effect of inflammation in the uterine cavities of women with cesarean scar syndrome on infertility at a single university hospital. The frequency of chronic endometritis in infertile patients was retrospectively compared between the cesarean scar syndrome group and non-cesarean scar syndrome group. The frequency of endometriosis was also investigated in patients with cesarean scar syndrome who underwent laparoscopy. The level of tumor necrosis factor-α and interleukin-1β in the uterine cavity was prospectively evaluated in the cesarean scar syndrome group and in women with a history of cesarean section (control group) using an enzyme-linked immunosorbent assay. There was a significant difference in the incidence of chronic endometritis between the cesarean scar syndrome and non-cesarean scar syndrome groups (65.8% and 46.0%, respectively, p = 0.0315). Endometriosis was detected in 51 (70%) patients with laparoscopy. Tumor necrosis factor-α and interleukin-1β levels in the cesarean scar syndrome group were significantly higher than those in the control group (p = 0.0002 and p = 0.0217, respectively). Our findings suggest that one cause of secondary infertility in women with cesarean scar syndrome is embryo implantation failure-associated chronic endometritis, endometriosis, and chronic inflammation in the uterine cavity.

Identifiants

pubmed: 36244756
doi: 10.1620/tjem.2022.J082
doi:

Substances chimiques

Interleukin-1beta 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

237-242

Auteurs

Yuri Nobuta (Y)

Department of Obstetrics and Gynecology, Shiga University of Medical Science.

Shunichiro Tsuji (S)

Department of Obstetrics and Gynecology, Shiga University of Medical Science.

Jun Kitazawa (J)

Department of Obstetrics and Gynecology, Shiga University of Medical Science.

Tetsuro Hanada (T)

Department of Obstetrics and Gynecology, Shiga University of Medical Science.

Akiko Nakamura (A)

Department of Obstetrics and Gynecology, Shiga University of Medical Science.

Rika Zen (R)

Department of Obstetrics and Gynecology, Shiga University of Medical Science.

Tsukuru Amano (T)

Department of Obstetrics and Gynecology, Shiga University of Medical Science.

Takashi Murakami (T)

Department of Obstetrics and Gynecology, Shiga University of Medical Science.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH